BENLYSTA has successfully met its primary endpoint in two pivotal Phase 3 trials in systemic lupus.

BENLYSTA已经成功地达到其主要终点的两个关键第三阶段试验的系统性。

youdao

BENLYSTA has successfully met its primary endpoint in two pivotal Phase 3 trials in systemic lupus.

BENLYSTA已经成功地达到其主要终点的两个关键第三阶段试验的系统性。

youdao